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The emergence and wide spread of multi-drug resistant Staphylococcus aureus
(S. aureus) requires the development of new therapeutic agents with alternative
modes of action. Anti-virulence strategies are hoped to meet that need. Sortase
A (SrtA) has attracted great interest as a potential drug target to treat infections
caused by S. aureus, as many of the surface proteins displayed by SrtA function as
virulence factors by mediating bacterial adhesion to specific organ tissues, invasion
of host cells, and evasion of the host-immune responses. It has been suggested that
inhibitors of SrtA might be promising candidates for the treatment and/or prevention
of S. aureus infections. In this study, we report that chlorogenic acid (CHA), a natural
compound that lacks significant anti-S. aureus activity, inhibit the activity of SrtA in
vitro (IC50 = 33.86 ± 5.55 μg/ml) and the binding of S. aureus to fibrinogen (Fg).
Using molecular dynamics simulations and mutagenesis assays, we further demonstrate
that CHA binds to the binding sites of C184 and G192 in the SrtA. In vivo studies
demonstrated that CHA prevent mice from S. aureus-induced renal abscess, resulting
in a significant survival advantage. These findings indicate that CHA is a promising
therapeutic compound against SrtA during S. aureus infections.
Keywords: sortase A, Staphylococcus aureus, chlorogenic acid, renal abscess, binding site, inhibitor
Introduction
Staphylococcus aureus (S. aureus) is an opportunistic pathogen which produces a wide spectrum
of diseases, ranging from minor skin infections and soft tissue infections to bacteraemia and
toxic shock syndrome. Bacteraemia frequently leads to infective endocarditis, osteomyelitis, septic
arthritis, and metastatic abscess formation (Lowy, 1998; Ippolito et al., 2010). S. aureus is
recognized as a prominent pathogen and has developed a wide range of resistance to antibiotics
(such as methicillin and vancomycin), as well as causing severe clinical complications and poor
outcomes (Vincent et al., 2006; Naber, 2009), making treatment options diﬃcult. The prevalence
of the antibiotic -resistant S. aureus isolates indicates the need for alternative therapy to treat
these infections (Ton-That and Schneewind, 1999). Recently, anti-virulence strategies to combat
bacteria-mediated infections have gained great interest.
The virulence factors of pathogens play a key role in the establishment of an infection. The
ability of S. aureus to cause disease has been generally attributed to two classes of virulence
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factors: cell surface proteins and extracellular protein toxins.
The surface proteins, such as protein A, clumping factor
and ﬁbronectin-binding proteins, mediate adhesion to
host endothelial tissues and evasion of host complement
proteins and immunoglobulin (Scott and Barnett, 2006). These
virulence-associated surface proteins are covalently anchored
to bacterial cell wall peptidoglycans through a general sorting
mechanism catalyzed by a superfamily of membrane-associated
transpeptidases termed sortases (Maresso and Schneewind,
2008). The sortase A (SrtA) isoform plays a critical role in the
pathological eﬀects of S. aureus (Maresso and Schneewind,
2008). Earlier work identiﬁed several srtA mutants defective for
anchoring ∼19 surface proteins with LPXTG sorting signals
to the cell wall envelope (Mazmanian et al., 2002). These srtA
mutants have decreased virulence and cannot cause lethal sepsis
or form abscesses in mouse models of staphylococcal disease
(Mazmanian et al., 2000; Cheng et al., 2009; McAdow et al.,
2011). Disrupting the display of these proteins by blocking the
activity of SrtA using an inhibitor could therefore eﬀectively
reduce bacterial virulence and thus promote bacterial clearance
by the host (Mazmanian et al., 2000). Attractively, SrtA inhibitors
may also be less likely to induce selective pressures that lead to
drug resistance, as these strains do not exhibit impaired growth
in culture medium outside of their human host (Mazmanian
et al., 1999). Therefore, SrtA is an attractive target to attenuate
virulence and hamper S. aureus infections.
Shortly after the discovery of SrtA, many studies toward
ﬁnding a potent inhibitor have been conducted over the past
decade. Multiple classes of molecules able to inhibit sortase
has been identiﬁed, including non-speciﬁc inhibitors, peptide-
analogs, natural products, and synthetic small molecules, which
is the ﬁrst step in the development of chemotherapeutics to be
used in the clinic (reviewed in Clancy et al., 2010; Zhang et al.,
2014).
Currently, research work in our group mainly focuses
on ﬁnding new molecules from traditional Chinese medicine
(TCM) against key virulence factors in bacteria. Inhibitors of
the α-Hemolysin (Hla) of S. aureus and Listeriolysin O of
Listeria monocytogenes have been reported recently (Qiu et al.,
2012; Wang et al., 2014). By detecting the inhibition rate of
enzyme activity, we have screened anti-Sa-SrtA molecules from
TCM which have detoxiﬁcation eﬀects. Several compounds
from medicinal herbs have been identiﬁed. We had a strong
interest in chlorogenic acid (CHA) because of its relatively high
inhibitory activities. CHA (Figure 1A) is a major component
of Flos Lonicerae, which is one of the most common TCMs
used for the treatment of various diseases including infections,
fever, swelling, sores, and arthritis for 1000s of years (Wu,
2007). Pharmacological data obtained from in vivo and in vitro
experiments show that CHA has a broad spectrum of biological
activities, such as antibacterial, antioxidant, anti-inﬂammatory,
antigenotoxic, anticancer and cytostatic activities and a relatively
low toxicity, which indicates that CHA could be a potential
leader drug (Niggeweg et al., 2004; dos Santos et al., 2006;
Abraham et al., 2007; Chauhan et al., 2012; Weng and Yen,
2012). Although CHA has an obvious inhibitory eﬀect on the
growth of both Gram-negative and Gram-positive bacteria (Sung
and Lee, 2010; Lou et al., 2011; Li et al., 2014), the minimum
inhibitory concentrations (MICs) are relatively high. Therefore,
the antibacterial activity of CHA would not be a reasonable
explanation for its treatment of infectious diseases.
We systematically study herein the activity of CHA as
a novel class of Sa-SrtA inhibitors in vitro. Moreover, we
assessed the potential therapeutic eﬀect of CHA on S. aureus-
induced renal abscesses in a mouse model of infection.
The mechanism of inhibition was further investigated using
molecular dynamics simulations and conducting preliminary
structure–activity relationship studies. To our knowledge, this is
the ﬁrst example of a SrtA inhibitor from a natural product to
be evaluated for in vitro activity, adaptation symptoms and the
molecular mechanism of interaction with the active site of the
enzyme.
Materials and Methods
Bacterial Strains, Plasmids, and Growth
Conditions
The bacterial strains and plasmids used in the present study
are described in Table 1. The SrtA strain was constructed
from Newman D2C in the previous study by our team (Chen
et al., 2013). Escherichia coli strain was grown in Luria-Bertani
broth (LB) at 37◦C while shaking and was supplemented,
if required, with ampicillin (100 μg/mL). S. aureus strains
were grown in brain-heart infusion (BHI) broth (Sigma)
at 37◦C under vigorous shaking and were supplemented,
when required, with erythromycin (Erm, 2.5 μg/mL) and
TABLE 1 | Strain and plasmid list.
Strain or plasmid Relevant genotype Reference
Strains
Staphylococcus aureus
Newman D2C wild-type SrtA positive;
non-hemolytic;
coagulase negative
ATCC25904
SrtA srtA::Erm; isogenic
mutant of Newman
D2C
Chen et al., 2013
Escherichia coli
BL21 Expression strain, F−
ompT hsdS(rB− mB−)
gal dcm (DE3)
Invitrogen
Plasmids
pGEX-6P-1 Expression vector Amersham
pGSrtAN59 pGEX-6P-1 with srtA
gene
This study
C184A pGSrtAN59
derivative, for the
substitution of Cys184
with alanine
This study
G192A pGSrtAN59
derivative, for the
substitution of Gly192
with alanine
This study
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chloramphenicol (15 μg/mL). S. aureus recombinant SrtA was
puriﬁed from E. coli strain BL21 (DE3) using GST aﬃnity
chromatography. Fluorescent peptide Dabcyl-QALPETGEE-
Edans was synthesized by GL Biochem (Shanghai, China). The
compound CHA was purchased from the National Institutes for
Food and Drug Control of China.
Construction of SrtAN59 and Mutant Protein
Expression Vectors
Primers designated as PsrtA59F and PsrtA59R were used
to amplify a SrtAN59 sequence (which would express
only residues 60–206) from genomic DNA from S. aureus
NewmanD2C, and they were cloned into the pGEX-6P-1
vector to generate the pGSrtAN59 construct. Site- directed
mutagenesis for C184A and G192A was performed as
described in the stratagene protocol (TransGen Biotech)
using pGSrtAN59 as the template. The complementary
forward and reverse primer pairs employed to construct the
SrtAN59 variants are listed in Table 2. All expression vectors
were conﬁrmed by DNA sequencing.
Expression and Purification of SrtAN59 and
Mutant SrtA
The pGSrtAN59 and mutant constructs were transformed
into E. coli strain BL21 (Invitrogen, Carlsbad, CA, USA). The
transformed cells were grown in LB broth with ampicillin
at 37◦C until the OD600 reached 0.6∼0.8. The culture was
then induced with 1 mM isopropyl â-D-1-thiogalactopyranoside
(IPTG, Invitrogen, Carlsbad, CA, USA) and grown overnight
at 16◦C. The cells were harvested and resuspended in the
reaction buﬀer (Tris-HCl 50 mM, CaCl2 5 mM, NaCl 150 mM,
pH 7.5). After sonication, the lysate was centrifuged, and the
supernatant was applied to a self-packaged GST-aﬃnity column
(2 mL glutathione Sepharose 4B; GE Amersham). After washing
oﬀ the unbound contaminating proteins, the GST -tagged protein
was digested with Precision Protease at 4◦C overnight and then
was eluted with reaction buﬀer. All samples were analyzed by
SDS-PAGE for the presence of the recombinant protein, and its
concentration was determined using the BCA protein assay kit
(Pierce).
Determination of SrtA Activity
The activity of CHA against SrtAN59 was determined using
a ﬂuorescence resonance energy transfer (FRET) assay. In this
assay, the IC50 value was determined by monitoring the eﬀect
TABLE 2 | Oligonucleotide primers used in this study.
Primer name Oligonucleotide (5–3)a
PsrtA59F GCGGGATCCCCGGAATTCCAAGCTAAACCTCAAATTCC
PsrtA59R CCGCTCGAGTTATTTGACTTCTGTAGCTACAA
C184A–F GCCTGTCTTTTCATTGTAATCATCAGCAGTAATTAATGTT
C184A–R GCTGATGATTACAATGAAAAGACAGGCGTTTGGGAAAAAC
G192A–F TATTTAATTGTTCAGCTGTTGCTGGT
G192A–R GCTGAACAATTAAATAGAGGTGTAA
a Restriction endonuclease recognition sites or mutated codons are underlined.
of CHA on the steady state cleavage of a model substrate
peptide, Dabcyl-QALPETGEE-Edans. FRET assay protocols have
been described previously (Ton-That et al., 1999; Mazmanian
et al., 2002). Brieﬂy, 300 μl of a mixture containing reaction
buﬀer, recombinant SrtA 4 mM, and increasing concentrations
of CHA was added to the 96-well plate and incubated for
30 min at 37◦C. Then, the assays were started with the
addition of the substrate modiﬁed peptide and run for 1 h at
37◦C. The sample ﬂuorescence was measured using emission
and excitation wavelengths of 495 and 350 nm, respectively.
Each experiment was repeated at least three times to ensure
reproducibility.
Determination of the MIC and Plotting of the
Growth Curves
The MIC of CHA was determined by broth microdilution
according to the NCCLS guideline M31-A2. CHA was dissolved
in dimethyl sulfoxide (DMSO) and diluted with sterilized distilled
water before use (ﬁnal 0.5% DMSO, which was found to have no
eﬀect on enzyme activity). For Growth Curve Plotting, 1 mL of
overnight bacterial cultures of S. aureus were added to 50 mL
of fresh BHI broth and incubated at 37◦C with or without CHA
for diﬀerent lengths of time. 0.5% DMSO was added to control
cultures. The absorbency reading was taken at OD600.
Fibrinogen-Binding Assay
The S. aureus wild-type strain was grown in BHI broth to the
exponential phase using incubation in a shaking incubator at
37◦C, diluted to an initial OD (600 nm) of 0.05, and with diﬀerent
concentrations of CHA added. The Newman SrtA strain was
grown under the same conditions as the positive control. All of
the samples were cultivated for 2 h on a rotary shaker at 37◦C.
The cells were pelleted by centrifugation (5,000 × g for 5 min),
washed twice and resuspended in PBS to an OD600 of 1.0.
Polystyrene Costar 96-well plates were coated overnight at 4◦C
with 100 μl of a 20 μg/ml bovine Fibrinogen (Fg). Plates were
washed and blocked for 2 h at 37◦C with BSA. After washing
with PBS, 100 μl of cell suspension was added and incubated
for 2 h at 37◦C. The cell suspension was removed. The adherent
bacterial cells were ﬁxed with 25% (v/v) formaldehyde for 30 min
after washing, and 100 μl crystal violet dye (12.5 g/l) was added
and incubated for 10 min. The plate was washed again and dried,
and then the absorbance of the plate was subsequently read at
570 nm with a Microplate reader. The results were reported as
the percentage of the adherence rate compared to the wild type
control. Each experiment was repeated at least three times to
ensure reproducibility.
Western Blot Analysis
Solubilized cell wall proteins and the cytoplasmic membrane
were obtained as previously described (Hartford et al., 1997;
Mazmanian et al., 2000). The protein extracts were separated on
12% SDS-PAGE gels and transferred to polyvinylidine diﬂuoride
membranes (Wako Pure Chemical Industries, Ltd., Osaka,
Japan). The antibodies against S. aureus surface protein A was
purchased from Abcam, and against S. aureus SrtA was prepared
by our team members. HRP-labeled goat anti-chicken Igγ was
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purchased from Santa Cruz, and HRP-labeled goat anti-rabbit
IgG was purchased from Proteintech.
Animal Experiments
All experimental animals used in these studies were 6- to 8-
weeks-old female BALB/c mice obtained from the Experimental
Animal Center of Jilin University. The animal experiments
were approved by and conducted in accordance with the
guidelines of the Animal Care and Use Committee of Jilin
University.
Overnight cultures of S. aureus were inoculated 1:100 into
fresh BHI broth and grown for 3 h at 37◦C. Staphylococci
were washed with PBS twice and suspended in BHI broth.
Bacteria (2 × 109 CFU) were injected into the tail vein
for survival studies. For the kidney infection model, BALB/c
mice (N = 8 per group) were inoculated with 200 μl of
staphylococcal suspension (2 × 108 CFU) into the tail vein.
On the 6th day after infection, the mice were euthanized and
the kidneys were excised. The left kidneys were homogenized,
diluted in normal saline and plated in duplicate for the
determination of CFUs. The right kidneys from each group
of mice were ﬁxed in 10% formalin for 24 h at room
temperature. The tissues were embedded in paraﬃn, thin-
sectioned, stained with hematoxylin and eosin (H&E), and
examined by microscopy. All animal studies were performed
at least twice, and similar results were observed in all replicate
experiments.
Statistical Analysis
The statistical signiﬁcance of the survival studies was assessed
using Log-rank (Mantel-Cox); the signiﬁcance of bacterial
burden and percentage of Fg-binding were calculated using
the unpaired two-tailed Student’s t-test. The diﬀerences were
considered statistically signiﬁcant when P < 0.05.
The other materials and methods used are described in the
Supplementary materials section.
Results
CHA Inhibits the Activity of SrtA
The inhibitory activities from major components of detoxifying
herbs on SrtA were determined using a FRET assay (Ton-That
et al., 1999; Mazmanian et al., 2002; data not show). CHA,
the main component of Flos Lonicerae, had a high activity
relative to other tested compounds. Structurally, CHA is an
ester formed between quinic acid and trans-cinnamic acid,
which represents a new class of SrtA inhibitor (Figure 1A).
The percentage of inhibitory activity of CHA (diﬀerent
concentrations) against SrtA is shown in Figure 1B. We
determined that CHA exhibited potent sortase-inhibitory activity
with IC50 33.86 ± 5.55 μg/ml.
CHA has No Influence on S. aureus Growth
TheMIC values of CHA against tested S. aureus strains (S. aureus
ATCC25904, S. aureus ATCC25923, and S. aureus ATCC29213)
were all greater than 1024 μg/ml. We made a growth curve
for S. aureus ATCC25904 to determine if the growth time
changed when the CHA (256 μg/ml) was added to the BHI
broth. We observed that the growth rate of S. aureus WT +
CHA and SrtA was similar to WT even the dosage is eight
times its IC50 (Figure 1C). The results indicate that CHA could
be a potential anti-virulence molecule which could eﬀectively
inhibit SrtA activity at a concentration far lower than the
MIC.
CHA Inhibits the Adhesion of S. aureus to
Fibrinogen
According to the preceding conclusions, CHA has considerable
inhibitory activity against SrtA. S. aureus can express up to
21 diﬀerent surface proteins, such as clumping factors (ClfA
and ClfB) and ﬁbronectin-bining proteins A and B (FnbA and
FnbB), many of which are covalently anchored to the cell wall
by the catalysis of sortase transpeptidase (Roche et al., 2003;
DeDent et al., 2008). Binding Fg and Fn are important for the
pathogenesis of S. aureus. S. aureusmutants lacking srtA will fail
to process and display surface proteins and are defective in the
establishment of infections (Mazmanian et al., 2000). It can be
inferred that CHA could interfere in Fg/Fn binding and attenuate
the virulence of S. aureus. Therefore, we employed Fg-binding
assays to test this hypothesis, in which cell adhesion to Fg-coated
plates was quantiﬁed by measuring the absorbance following
staining with crystal violet. First, the capacity of S. aureus strain
Newman D2C (WT) and its isogenic knockout mutant SrtA
to adhere to Fg-coated surfaces was investigated. As shown in
Figures 2A,B, the SrtA showed a minimum binding rate to
Fg, 3.7 ± 2.1%. The treatment of the WT strain with either
32, 64, 128, or 256 μg/ml of CHA was measured, and the
adhesion rates were 89.8 ± 5.2, 45.0 ± 4.3, 27.7 ± 5.1, and
16.7 ± 3.2% to Fg, respectively (Figure 2B). We observed
that the treatment of the WT strain with CHA reduced the
capacity of the bacterium to adhere to Fg in a dose-dependent
manner. When treating with 64, 128, 256 μg/ml of CHA, the
binding was signiﬁcantly reduced compared with that of the WT
(Figure 2B).
CHA Inhibits Transpeptidation Catalyzed by
SrtA
To determine whether CHA interferes with the function of
surface proteins by reducing the amount of protein functionally
displayed on the cell wall, we extracted cell wall-associated
proteins. In this study, we demonstrated byWestern blot analysis
using anti-SrtA antibody that CHA does not inﬂuence the
expression of SrtA. When performing Western blot analysis
of protein A in cell wall-associated extracts using anti-protein
A antibody, we found that protein A decreased remarkably
after incubating S. aureus with CHA (Figure 3). These results
demonstrated that CHA could be considered as an inhibitor to
directly aﬀect SrtA in vivo.
Determination of the Binding Mechanism of
SrtA with CHA
To explore the potential binding mechanism of CHA to SrtA,
molecular docking and molecular dynamics simulations were
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FIGURE 1 | (A) Structure of chlorogenic acid (CHA). (B) Inhibitory effects of CHA (different concentrations) against SrtA from Staphylococcus aureus Newman D2C
in vitro. (C) Growth diagram of S. aureus Newman D2C (WT) in the presence or absence of CHA (256 μg/ml) and SrtA.
performed using the AutoDock 4.0 and Gromacs 4.5.1 software
package. The initial structure of SrtAwas obtained from the X-ray
structure (PDB code: 1T2P; Zong et al., 2004). The preferential
binding mechanism of SrtA with CHA was determined by
20-ns molecular dynamics simulations based on the docking
results. To explore the dynamic stability of the models and
to ensure the rationality of the sampling strategy, the root-
mean-square deviation (RMSD) values of the protein backbone
based on the starting structure along the simulation time were
calculated and plotted in Figure 4A. As shown in Figure 4A, the
protein structures of all of the systems were stabilized during the
simulations.
In the simulation, CHA represents a ligand that can bind
to SrtA via hydrogen bonding and hydrophobic interactions.
Over the time course of the simulation, CHA localized to the
“activity” region, which is reported to participate in reactivity and
is important for SrtA (Ton-That et al., 1999, 2000). The predicted
binding mode of CHA with SrtA is illustrated in Figure 4B, and
the electrostatic potentials of the residues around the binding
site were mapped using APBS software (Baker et al., 2001). In
detail, the binding model of CHA with the activity region of SrtA
(Figure 4B) revealed that the hydroxyl group of the cyclohexane
of CHA formed hydrogen bonds with both the side CHA in
amino of Arg197 and the backbone of Gly192. Moreover, the side
chains of Cys184 and Ile182 can form Van derWaals interactions
with CHA, as shown in Figure 4B, which was conﬁrmed by
energy decomposition analysis.
The root mean square ﬂuctuations (RMSF) of the residues of
the whole protein in the SrtA-CHA complex and in free SrtAwere
calculated to reveal the ﬂexibility of these residues. The RMSF of
these residues are shown in Figure 4C, clearly depicting diﬀerent
ﬂexibilities in the binding site of SrtA in the presence and absence
of CHA. All of the residues in the SrtA binding site that bind
with CHA show a small degree of ﬂexibility with a RMSF of less
than 3.00 Å when compared with free SrtA, indicating that these
residues seem to be more rigid as a result of binding to CHA.
The above information indicated that the stabilization at the
binding cavity of SrtA in this complex was mostly due to residues
Ile182, Cys184, Gly192 and Arg197, as is shown in Figure 4B.
Identification of the Binding Site in the
SrtA-CHA Complex
To gain more information about the residues surrounding the
binding site and their contribution to the whole system, the
electrostatic, Van der Waals, solvation, and total contribution
of the residues to the binding free energy were calculated
with the Molecular MeCHAnics Generalized Born Surface Area
(MM-GBSA) method (Punkvang et al., 2010; Schaﬀner-Barbero
et al., 2010). The calculation was performed over the 100 MD
snapshots taken from the last 10-ns simulation. The summations
of the per residue interaction free energies were separated into
Van der Waals (Evdw), electrostatic (Eele), solvation (Esol),
and total contribution (Etotal). The energy contributions from
the selected residues are summarized in Figure 4D-a. As
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FIGURE 2 | Fibrinogen (Fg)-binding assays. The value of the SrtA as the ideal sortase inhibitor was used as a positive control. (A) The results could be
inspected directly. (B) Adhesion rate of bacterial cells to Fg. CHA reduced the adhere of WT to Fg in a dose dependent manner. Each result was derived from three
independent experiments and presented as the mean ± SEM. ∗∗P < 0.01 vs. the WT group.
shown, in the SrtA-CHA complex, Arg197 and Gly192 have an
appreciable electrostatic (Eele) contribution, with a Eele of
≤ −3.0 kcal/mol (Figure 4D-a). In fact, Arg197 and Gly192 are
close to the cyclohexane group of CHA, and two electrostatic
interactions exist, leading to two strong H-bonds between SrtA
and CHA. In addition, residue Ile182 and Cys184, with a Evdw
of ≤ −2.0 kcal/mol, have strong Van der Waals interactions with
the ligand because of the close proximity between the residues
and CHA. Except for residues Gly192 and Arg197, the majority
of the decomposed energy interaction originated from Van der
Waals interactions, apparently through hydrophobic interactions
FIGURE 3 | Western blot analysis of sortase A (SrtA) protein and
protein A (Spa). Proteins released from the cytoplasmic membrane (SrtA) or
cell wall (Spa) of S. aureus Newman D2C (lanes 1, 3–8) and SrtA (lane 2)
grown in the absence or in the presence of CHA were fractionated by
SDS-PAGE, transferred to polyvinylidene fluoride membranes. SrtA was
detected with specific anti-SrtA rabbit antibodies and Spa was detected with
specific anti-protein A chicken antibodies.
in the formation of the SrtA-CHA complex. In addition, the
total binding free energy for the SrtA-CHA complex and its
detailed energy contributions calculated according to the MM-
GBSA approach are summarized in Table 3. With the summation
of the solute entropy term (∼6.7 kcal/mol), an estimated Gbind
of −15.2 kcal/mol was found for CHA, suggesting that CHA
can strongly bind to and interact with the binding site of
SrtA.
To examine the accuracy of the binding site in the SrtA-CHA
complex, the mutant complexes of C184A-CHA and G192A-
CHA were used as preliminary structures for MD simulations,
and the MD trajectories were successively analyzed with the MM-
GBSA method. The C184A and G192A mutants were expressed
and puriﬁed, and the binding constants and number of binding
sites between CHA and the two mutants were investigated by
the ﬂuorescence spectroscopy quenching method (Lakowicz and
Weber, 1973).
As shown in Figure 4D-b,c, CHA binds to the two mutants
and the WT-SrtA similarly, which was conﬁrmed by the
pair interaction decomposition of the free energy. The major
contribution to the free energy was from Ile182, Cys184, Gly192,
and Arg197. However, the MM-GBSA calculation predicted that
C184A and G192A bound more weakly to CHA than did the
WT-SrtA (−7.9 kcal/mol for C184A and −8.4 kcal/mol for
G192A), as shown in Table 3. The calculations for C184A and
G192A revealed that these mutants resulted in a decrease of
∼7 kcal/mol of binding energy compared toWT-SrtA. According
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FIGURE 4 | (A) The root-mean-square deviations (RMSDs) of all the atoms of SrtA-CHA complexes with respect to their initial structures as function of time. (B) The
predicted binding mode of CHA in SrtA binding pocket obtained from MD simulation. (C) RMSF of residues of the whole protein in SrtA-CHA complex and free SrtA
during the last 10-ns simulation time. (D) Decomposition of the binding energy on a per-residue basis in the SrtA-CHA complex (a), C184A-CHA complex (b), and
G192A-CHA complex (c).
to the experimental results, the binding constants, KA, of the
interaction between CHA and SrtA decrease in the following
order: WT > G192A > C184A, which means that WT-SrtA has
the strongest ability to bind to CHA and C184A has the weakest
ability, as shown in Table 3. The calculated binding free energies
are in agreement with the experimental data. We believe that the
MD simulations generated a reliable SrtA-CHA complex.
The residues of Ile182, Cys184, Gly192, and Arg197 have a
key role in the binding process of SrtA with the substrate (Ton-
That et al., 1999, 2000). Due to the binding of CHA with the
activity region (residues of Ile182, Cys184, Gly192, and Arg197),
the biological activity of SrtA was inhibited.
The Effect of CHA on the Survival Rate of Mice
Inoculated with S. aureus
Based on the in vitro ﬁndings above, we further investigated the
protective eﬀects of CHA in vivo. According to our previous
study, 2 × 109 CFU and 2 × 108 CFU of S. aureus was injected
during the survival and renal abscess experiments, respectively
(Wang et al., 2015). Nine days after infection with 2 × 109 CFU
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TABLE 3 | The calculated energy components, binding free energy (kcal/mol), binding constants, and the number of binding sites using the fluorescence
spectroscopy quenching method in the WT-CHA, C184A-CHA, and G192A-CHA systems.
TS
(kcal/mol)
Gbind
(kcal/mol)
Binding constants KA
(1 × 105) L·mol−1
n
WT-CHA 6.7 ± 2.0 −15.2 ± 2.4 8.9 ± 1.3 0.9987
C184A-CHA 5.9 ± 1.4 −7.9 ± 1.6 4.7 ± 0.8 1.0025
G192A-CHA 6.3 ± 1.3 −8.4 ± 1.9 5.0 ± 0.9 0.9995
of S. aureus, the WT strain had produced signiﬁcantly greater
mortality, killing 90% of the mice within 7 days, compared with
SrtA strains, in which the mortality rate was 0% (Figure 5).
WT-infected mice received a hypodermic injection of CHA at
doses of 150 mg/kg/d. The survival analyses revealed that the
WT+CHA group exhibited a signiﬁcant survival advantage,
particularly at early time points post-infection (Figure 5). The
mice of the WT+CHA group started to die on day 5 post-
injection (the day we stopped administrating the drugs). These
results indicated that CHA can prolong survival and protect mice
from death early in infection.
CHA Protects Mice from S. aureus-Induced
Renal Abscess
Following entry into the bloodstream, S. aureus escapes
phagocytic killing by immune cells and, after binding to speciﬁc
tissues, causes abscesses in organs (Lee et al., 1987). Surface
proteins such as ClfA and FnbpA, which are displayed by SrtA,
play an important role in this process (Cheng et al., 2009). To test
the eﬀect of CHA, a potential SrtA inhibitor, on the pathogenesis
of staphylococcal diseases, we investigated the formation of renal
abscesses in a mouse model of infection. In this model, 2 × 108
CFU of S. aureus was used for infection (Wang et al., 2015).
CHA (150 mg/kg/d) was hypodermically injected post-injection
of S. aureus. The histopathology analysis of the kidneys from
animals infected for 24 h revealed no appearance of abscesses
on organ surfaces. The number of kidneys with surface abscesses
increased to 25% by 72 h and to 70% on day 6. Six days after
FIGURE 5 | Effects of CHA on survival rates after 9-days monitoring of
BALB/c mice. Survival percentage of BALB/c mice (N = 10) after challenged
with intravenous injection of 2 × 109 CFU of S. aureus (WT) and SrtA.
Treatment with CHA (50 mg/kg, three times a day) was initiated after
inoculation. Survival statistics were calculated by Log-rank (Mantel–Cox) test.
The statistical significance determined as follows: WT vs. SrtA, P < 0.0001;
WT vs. WT+CHA, P < 0.05.
infection, the mice were euthanized and the kidneys were excised.
The left kidneys were homogenized for determination of the
staphylococcal load in renal tissue. We observed a mean of
6 × 106 CFU/g of renal tissue for S. aureus Newman D2C, 40
CFU/g for S. aureus SrtA (P < 0.01 vs. the WT group) and 104
CFU/g for the CHA-treated group (P < 0.01 vs. the WT group;
Figure 6P). After observing surface abscesses by microscopy
at 10×, the right kidneys were ﬁxed in 10% formalin. The
tissues were embedded in paraﬃn, thin-sectioned, stained with
hematoxylin and eosin (H&E), and examined by microscopy. As
shown in Figure 6, the kidneys from mice challenged with WT
had abscesses covering a large surface area (>50% of Surface;
Figure 6A) and enclosed a central population of staphylococci,
surrounded by a layer of eosinophilic, amorphous material
and a large cuﬀ of polymorphonuclear leukocytes (PMNs;
Figures 6B–E; Cheng et al., 2009). SrtA failed to form abscess
lesions on either macroscopic or histopathological examination
(Figures 6F–J). Sizes of the abscesses were signiﬁcantly decreased
after treatment with CHA, only a slight inﬂux of PMNs was
observed and there were a few discernible organizations of
staphylococci (Figures 6K–O). These results indicate that SrtA
is an important factor in the S. aureus-mediated formation of
renal abscesses. Furthermore, CHA prevents mice from forming
S. aureus-induced renal abscess and relieves the infection.
Discussion
The widespread occurrence of methicillin-resistant S. aureus
(MRSA; Otto, 2012) and vancomycin-resistant strains (VRSA;
Welsh et al., 2010) creates an urgent need for new therapeutic
agents to treat S. aureus infections. Traditional antibiotics act
by preventing the synthesis and assembly of key components
of bacterial processes that are essential for growth, which
results in substantial stress on the target bacterium and rapidly
selects for resistant subpopulations. Searching for a virulence
inhibitor is one of the alternative approaches to ﬁnd molecules
with radically new mechanisms of action to treat infections
caused by multidrug resistant bacteria (Rasko and Sperandio,
2010). Because most virulence traits are not essential for
bacterial growth, this strategy might decrease the development
of resistance by not inducing selective pressures (Rasko and
Sperandio, 2010).
The key virulence factors produced by S. aureus include
surface adhesion proteins and extracellular toxins responsible for
the colonization of and damage to mammalian hosts (Schlievert
et al., 2000). Among ∼30 exoproteins that S. aureus produces,
α-Hemolysin (Hla) is the only one that is necessary for the
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FIGURE 6 | Chlorogenic acid protects against S. aureus-induced abscess formation in kidney of BALB/c mice. Kidneys of BALB/c mice (N = 8 per group)
infected with 2 × 108 CFU S. aureus Newman D2C (WT), SrtA or WT after treatment with CHA (50 mg/kg, three times a day) were removed from mice on the
6 days after intravenous infection. (A–P) Kidneys were inspected for surface abscesses (A,F,K) or fixed in formalin, embedded, thin sectioned and stained with H&E.
Histopathology images were acquired with light microscopy at ×100 (B,C,G,H,L,M) and ×400 (D,E,I,J,N,O). Kidneys from mice challenged with WT had a big size
of abscesses and enclosed a central population of staphylococci (D, yellow arrowheads), surrounded by a layer of eosinophilic, amorphous material and a large cuff
of polymorphonuclear leukocytes (PMNs; D,E, blue rectangular box). There is no abscess founded in kidneys from mice infected with SrtA. Sizes of abscesses were
significantly decreased after treated with CHA. Only some slight influx of PMNs (N, blue rectangular box) existed and harbored a few discernable organization of
staphylococci (N, yellow arrowheads). (P) Bacterial burden in kidney tissue was measured on the 6 days after intravenous infection. Mean ± SEM of staphylococcal
load were calculated as log10 CFU/g in homogenized renal tissues. Statistical significance was calculated with the Student’s t-test; ∗∗P < 0.01 vs. the WT group.
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pathogenicity of this bacterium (Wardenburg et al., 2007).
Therefore, Hla could be a potential anti-virulence target to
treat S. aureus infections. However, this type of pore-forming
cytotoxin is quite diﬀerent in its structure and function among
bacterial species (Gonzalez et al., 2008). SrtA mediates the
covalent attachment of up to 19 surface proteins to the cell wall,
and it is very important for the tissue colonization and infection
of S. aureus. SrtA represents another promising anti-virulence
target (Maresso and Schneewind, 2008). Unlike the pore-forming
cytotoxin, SrtA is a “housekeeping” sorting enzyme, and its
homologs are conserved and can be found in almost all Gram-
positive bacteria (Papadopoulos and Agarwala, 2007). As a target
candidate for the treatment of Gram-positive bacterial infections,
SrtA has drawn much attention since its identiﬁcation ∼15 years
ago (Mazmanian et al., 1999).
The search for inhibitors of SrtA have involved natural,
synthetic, and high-throughput screening methodologies, and
several distinct inhibitor classes have been identiﬁed (Maresso
and Schneewind, 2008; Clancy et al., 2010). Among the inhibitors,
only two chemically synthesized small molecules had a protective
eﬀect against S. aureus infections in vivo (Zhang et al., 2014).
Nevertheless, the molecular mechanism of the interaction
between the small molecules and enzyme remain unclear.
We have tried to ﬁnd potent inhibitors from a number of
natural small molecule compounds. CHA, an ester of caﬀeic and
quinic, belongs to the phenylpropanoids and is quite structurally
diﬀerent from the known SrtA inhibitors (Figure 1A). At a
concentration largely below the MIC, CHA could signiﬁcantly
inhibit the catalytic activity of SrtA in vitro, which means
that the compound would be able to reduce the virulence of
the pathogenic bacteria without exerting a noticeable selective
pressure. We also evaluated the in vivo eﬀects of CHA in a
BALB/c mouse model. The results indicated that CHA could
inhibit SrtA activity in mice, thereby causing a reduction in both
the mortality rate and the formation of renal abscesses.
The wild type S. aureus that we used in this study was Newman
D2C, which has been reported as a new reference strain for SrtA
studies (Miller et al., 1977) due to its being coagulase-negative
(Yonemasu et al., 1987, 1991) and non-hemolytic (Chen et al.,
2013). To our current knowledge, SrtA is the most important
virulence factor in this strain, and therefore this strain has an
advantage for studying the function of SrtA and the activity of
SrtA inhibitors. Consequently, a srtA mutant strain, SrtA, was
constructed based on the wild-type NewmanD2C in our previous
research (Chen et al., 2013).
Chlorogenic acid is a major component of Flos Lonicerae.
The ancient herb has been used in the treatment of infectious
diseases for 1000s of years (Wu, 2007). The oral and injectable
preparations are also widely used in China currently (Cliﬀord,
2000; Lou et al., 2011). The bioavailability and safety of CHA
would be a prominent advantage over the synthesis inhibitors
of SrtA that have been previously reported, although the IC50 of
CHA is relatively high compared with those compounds.
Resent research demonstrated that CHA can also signiﬁcantly
down-regulate the expression level of enterotoxins (SEs) and
α-toxin, which are important in the pathogenesis of S. aureus
infections (Li et al., 2014). Taken together, through interference
with both surface adhesins and exotoxins, CHA could havemulti-
faceted anti-virulence activity. It also could be more diﬃcult for
bacteria to develop resistance to these actions of CHA.
In this study, we also revealed the binding mechanism of
CHA with SrtA by the molecular simulation method. The results
indicated that CHA tightly occupied the active site of SrtA.
According to the previous study, the β6/β7 loop, β7/β8 loop and
the active residues Arg197, H120, and C184 are the key structural
elements involved in the catalysis reaction (Suree et al., 2009).
The mobile β6/β7 loop plays an important role in the substrate-
speciﬁc recognition and catalysis of SrtA (Bentley et al., 2007,
2008). The aromatic ring of CHA is placed in the sorting signal
recognition region of SrtA through hydrophobic interactions
with the side chains of residues from the β6/β7 loop (Val169,
Leu168). The RMSF comparison of the residues of the apo-
SrtA and CHA-SrtA complexes revealed that CHA signiﬁcantly
immobilizes the ﬂexible β6/β7 loop, similar to the conformational
changes induce by the binding of natural substrates. Thus, the
binding of CHA would substantially interfere with substrate
recognition, the initial step of the transpeptidation reaction of
SrtA. Arg197 is essential in the catalysis of SrtA by stabilizing the
positioning of the substrate peptide and stabilizing the tetrahedral
intermediates of catalysis through interaction between its side
chain and the oxyanion. In the docking model of CHA-SrtA,
the guanidine group of Arg197 formed H-bonds with the –OH
of the cyclohexane moiety of CHA. Through the hydrophobic
interactions between the side chains of Cys184 and Ile 182 and
the central region of CHA, the complex was further stabilized in
the active site. Upon binding of the natural substrate peptide, the
β7/β8 of SrtA undergoes a dramatic conformation change and
creates a new groove, which serves as a binding site for Lipid II.
The hydroxyl group of the cyclohexane, which occupies the Lipid
II site of SrtA, forms another hydrogen bond with the backbone
carbonyl of Gly192 and keeps the β7/β8 loop in a closed state in
the CHA-SrtA complex.
This evidence suggests that, through preventing the access and
binding of the SS (sorting signal) of the surface protein to the
active site, CHA eﬀectively inhibits the transpeptidation of SrtA.
This would be critical information for further reasonable design
of more powerful inhibitors. We are currently conducting studies
regarding structural modiﬁcations of CHA and the evaluation
of its inhibition against SrtA from S. aureus and other Gram-
positive bacteria.
Conclusion
We have determined that CHA is a novel SrtA inhibitor
which is quite diﬀerent structurally from the chemical moieties
reported previously. In vivo, CHA signiﬁcantly interferes in
the pathogenesis of S. aureus and provides protection against
renal abscess formation in murine models. For the ﬁrst time,
the detailed interactions between SrtA and the inhibitor were
analyzed. This should pave the way for the generation of CHA
derivatives with higher potency against SrtA and lead to the
development of eﬀective and clinically useful anti-virulence
agents.
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